What is Hillenbrand, Inc.'s earnings per share (EPS)?

Hillenbrand, Inc. (HI) reported diluted earnings per share of $0.61 for fiscal year 2025. This represents a 120.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Hillenbrand, Inc. (HI) Financials

Trailing 12 months to December 31, 2025

Revenue $2.5B -19.2% YoY

Net Income $34.5M +115.6% YoY

EPS (Diluted) $0.49 +115.6% YoY

Free Cash Flow $7.8M -94.9% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Dec 31, 2025 Reported Feb 9, 2026 Currency USD FYE September

Newest figures come from the 10-Q for Q1 FY2026, filed Feb 9, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HI SEC filings page.

Hillenbrand, Inc. (HI) reported $2.5B in revenue over the twelve months to Dec 31, 2025, down 19.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HI FY2025 2026-10-03

Hillenbrand's revenue contraction left gross margin intact, but cash generation weakened while balance-sheet deleveraging reduced financial obligations.

In FY2025, net income returned to positive territory at $43M, yet operating cash flow fell to $56M from $191M in FY2024 and free cash flow fell to $18M from $137M. That split means the earnings recovery did not translate into comparable cash generation, leaving little cash after capital spending.

Revenue contracted 16.0% in FY2025, yet gross margin rose from 33.2% to 33.7%. That combination points to a top-line volume or mix problem rather than worsening unit economics at the gross-profit level.

Debt-to-equity eased to 1.1x, while the current ratio declined to 1.2x; deleveraging therefore came alongside a thinner short-term cushion. Long-term debt also fell to $1.5B, consistent with reduced balance-sheet obligations rather than merely an equity increase.

Financial Health Signals

Financial Health Score 22/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Hillenbrand, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Not available for Hillenbrand, Inc., and counted as zero in the overall score.

Growth

Hillenbrand, Inc.'s revenue declined 16.0% year-over-year, from $3.2B to $2.7B. This contraction results in a growth score of 21/100.

Leverage

Hillenbrand, Inc. has a moderate D/E ratio of 1.08. This balance of debt and equity financing earns a leverage score of 45/100.

Liquidity

Hillenbrand, Inc.'s current ratio of 1.22 is below the typical benchmark, resulting in a score of 29/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Hillenbrand, Inc. has a free cash flow margin of 0.7%, earning a moderate score of 35/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Not available for Hillenbrand, Inc., and counted as zero in the overall score.

Piotroski F-Score Neutral

6/9

Hillenbrand, Inc. passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.30x

For every $1 of reported earnings, Hillenbrand, Inc. generates $1.30 in operating cash flow ($56.2M OCF vs $43.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$550.2M

YoY-22.2%

QoQ-15.6%

5Y CAGR-4.5%

10Y CAGR+4.6%

Hillenbrand, Inc. generated $550.2M in revenue in Q1 2026. This represents a decrease of 22.2% from the same quarter a year earlier. Against the prior quarter it is down 15.6%.

Net Income

-$2.2M

YoY-134.4%

QoQ-102.9%

Hillenbrand, Inc. reported -$2.2M in net income in Q1 2026. This represents a decrease of 134.4% from the same quarter a year earlier. Against the prior quarter it is down 102.9%.

EPS (Diluted)

-$0.03

YoY-133.3%

QoQ-102.8%

Hillenbrand, Inc. earned -$0.03 per diluted share (EPS) in Q1 2026. This represents a decrease of 133.3% from the same quarter a year earlier. Against the prior quarter it is down 102.8%.

EBITDA

Not reported for Q1 2026.

Cash & Balance Sheet

Free Cash Flow

-$31.6M

YoY-47.0%

QoQ-153.9%

Hillenbrand, Inc. recorded an outflow of $31.6M in free cash flow in Q1 2026, representing a cash shortfall after capex. This represents a decrease of 47.0% from the same quarter a year earlier. Against the prior quarter it is down 153.9%.

Cash & Debt

$173.1M

YoY-16.8%

QoQ+5.0%

5Y CAGR-8.2%

10Y CAGR+12.1%

Hillenbrand, Inc. held $173.1M in cash against $1.6B in long-term debt as of Q1 2026.

Shares Outstanding

71M

YoY+0.3%

QoQ+0.2%

5Y CAGR-1.2%

10Y CAGR+1.2%

Hillenbrand, Inc. had 71M shares outstanding in Q1 2026. This represents an increase of 0.3% from the same quarter a year earlier. Against the prior quarter it is up 0.2%.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Gross Margin

33.4%

YoY+0.2pp

QoQ-1.4pp

5Y change-1.9pp

10Y change-3.1pp

Hillenbrand, Inc.'s gross margin was 33.4% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.4 percentage points.

Net Margin

-0.4%

YoY-1.3pp

QoQ-12.0pp

5Y change-11.4pp

10Y change-6.4pp

Hillenbrand, Inc.'s net profit margin was -0.4% in Q1 2026, showing the share of revenue converted to profit. This is down 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 12.0 percentage points.

Return on Equity

-0.1%

YoY-0.6pp

QoQ-5.6pp

5Y change-6.6pp

10Y change-3.7pp

Hillenbrand, Inc.'s ROE was -0.1% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.6 percentage points.

Operating Margin

Not reported for Q1 2026.

Capital Allocation

Capital Expenditures

$4.2M

YoY-58.8%

QoQ-53.8%

5Y CAGR-5.6%

10Y CAGR-4.3%

Hillenbrand, Inc. invested $4.2M in capex in Q1 2026, funding long-term assets and infrastructure. This represents a decrease of 58.8% from the same quarter a year earlier. Against the prior quarter it is down 53.8%.

R&D Spending

Not reported for Q1 2026.

Share Buybacks

Not reported for Q1 2026.

HI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HI quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$2.5B	$2.7B-16.0%	$3.2B+12.6%	$2.8B+22.1%	$2.3B+3.3%	$2.2B-10.9%	$2.5B+39.3%	$1.8B+2.1%	$1.8B+11.3%	$1.6B+3.4%	$1.5B-3.7%	$1.6B-4.2%	$1.7B+7.3%	$1.6B+58.0%	$983.2M+11.3%	$883.4M
Cost of Revenue	$1.7B	$1.8B-16.6%	$2.1B+13.2%	$1.9B+21.0%	$1.6B+2.8%	$1.5B-11.4%	$1.7B+43.9%	$1.2B+5.0%	$1.1B+12.9%	$999.4M+3.3%	$967.8M-5.7%	$1.0B-4.8%	$1.1B+4.2%	$1.0B+74.1%	$594.3M+15.7%	$513.5M
Gross Profit	$849.5M	$900.8M-14.7%	$1.1B+11.4%	$948.2M+24.1%	$763.8M+4.3%	$732.3M-10.0%	$813.3M+30.5%	$623.0M-3.0%	$642.1M+8.7%	$590.8M+3.5%	$570.6M0.0%	$570.4M-3.2%	$589.2M+13.6%	$518.7M+33.4%	$388.9M+5.1%	$369.9M
R&D Expenses	N/A	$34.1M-7.1%	$36.7M+44.5%	$25.4M+28.3%	$19.8M-2.5%	$20.3M+9.1%	$18.6M+75.5%	$10.6M-9.4%	$11.7M-1.7%	$11.9M-5.6%	$12.6M-0.8%	$12.7M-11.8%	$14.4M+18.0%	$12.2M+134.6%	$5.2M+15.6%	$4.5M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$174.5M+47.8%	$118.1M-20.6%	$148.8M-6.2%	$158.6M
EBITDA	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$232.9M+12.2%	$207.5M+9.7%	$189.2M-2.8%	$194.7M
Interest Expense	$89.6M	$94.5M-22.2%	$121.5M+56.4%	$77.7M+20.8%	$64.3M-13.5%	$74.3M-4.0%	$77.4M+182.5%	$27.4M+17.6%	$23.3M-7.5%	$25.2M-0.4%	$25.3M+6.3%	$23.8M+2.1%	$23.3M-2.9%	$24.0M+93.5%	$12.4M+12.7%	$11.0M
Income Tax	-$73.8M	-$54.5M-184.1%	$64.8M-37.0%	$102.8M+22.4%	$84.0M+6.9%	$78.6M+125.2%	$34.9M-30.9%	$50.5M-22.7%	$65.3M+9.0%	$59.9M+26.6%	$47.3M-3.7%	$49.1M+0.8%	$48.7M+72.1%	$28.3M-6.0%	$30.1M-41.8%	$51.7M
Net Income	$34.5M	$43.1M+120.4%	-$211.0M-137.0%	$569.7M+172.7%	$208.9M-16.4%	$249.9M+568.0%	-$53.4M-142.3%	$126.2M+55.4%	$81.2M-36.8%	$128.4M+9.9%	$116.8M+3.2%	$113.2M+1.8%	$111.2M+70.0%	$65.4M-37.6%	$104.8M-1.2%	$106.1M
EPS (Basic)	N/A	$0.61+120.3%	-$3.00-136.8%	$8.16+180.4%	$2.91-12.9%	$3.34+507.3%	-$0.82-142.5%	$1.93+59.5%	$1.21-39.2%	$1.99+11.8%	$1.78+1.1%	$1.76+1.1%	$1.74+72.3%	$1.01-39.9%	$1.68-1.8%	$1.71
EPS (Diluted)	$0.49	$0.61+120.3%	-$3.00-136.9%	$8.13+181.3%	$2.89-12.7%	$3.31+503.7%	-$0.82-142.7%	$1.92+60.0%	$1.20-39.1%	$1.97+11.3%	$1.77+1.7%	$1.74+1.2%	$1.72+70.3%	$1.01-39.9%	$1.68-1.8%	$1.71
Diluted Shares (Avg)	N/A	71M+0.6%	70M+0.4%	70M-2.9%	72M-4.2%	75M+2.7%	73M+16.0%	63M-0.8%	64M-0.3%	64M+0.3%	64M-0.2%	64M+0.2%	64M+1.3%	63M+1.0%	62M+0.6%	62M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$550.2M-22.2%	$652.1M-22.1%	$598.9M-23.9%	$715.9M-8.8%	$706.9M-8.6%	$837.6M+9.8%	$786.6M+9.8%	$785.3M+13.7%
Cost of Revenue	$366.5M-22.3%	$425.3M-22.6%	$396.3M-23.8%	$479.5M-10.3%	$471.9M-9.6%	$549.2M+10.9%	$520.2M+10.8%	$534.6M+15.0%
Gross Profit	$183.7M-21.8%	$226.8M-21.4%	$202.6M-23.9%	$236.4M-5.7%	$235.0M-6.4%	$288.4M+7.8%	$266.4M+7.9%	$250.7M+10.9%
Interest Expense	$20.2M-19.5%	$24.9M-13.2%	$21.3M-33.9%	$23.2M-24.7%	$25.1M-15.8%	$28.7M+31.7%	$32.2M+103.8%	$30.8M+65.6%
Income Tax	-$12.9M-301.6%	-$61.7M-201.0%	$6.5M+161.9%	-$5.7M-235.7%	$6.4M-36.0%	$61.1M+16.2%	-$10.5M-144.1%	$4.2M-82.6%
Net Income	-$2.2M-134.4%	$75.7M+418.5%	$1.9M+100.8%	-$40.9M-770.5%	$6.4M-62.8%	$14.6M-19.8%	-$248.9M-674.8%	$6.1M-98.7%
EPS (Basic)	-$0.03-133.3%	$1.07+435.0%	$0.03+100.8%	-$0.58-744.4%	$0.09-64.0%	$0.20-20.0%	-$3.53-669.4%	$0.09-98.6%
EPS (Diluted)	-$0.03-133.3%	$1.07+435.0%	$0.03+100.8%	-$0.58-744.4%	$0.09-62.5%	$0.20-20.0%	-$3.53-669.4%	$0.09-98.6%
Diluted Shares (Avg)	71M+0.4%	N/A	71M+0.4%	71M0.0%	71M+0.1%	N/A	71M+0.3%	71M+0.9%

Not reported in any period shown, so not listed: R&D Expenses, SG&A Expenses, Operating Income, EBITDA.

HI Balance Sheet

HI quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$4.5B-14.7%	$5.2B-5.6%	$5.5B+43.4%	$3.9B-3.7%	$4.0B+0.7%	$4.0B+78.9%	$2.2B+19.5%	$1.9B-4.7%	$2.0B-0.2%	$2.0B+8.4%	$1.8B-5.8%	$1.9B-4.2%	$2.0B+84.2%	$1.1B-7.9%	$1.2B
Current Assets	$1.2B-17.8%	$1.5B-6.1%	$1.6B+14.6%	$1.4B-2.2%	$1.4B+4.7%	$1.4B+33.9%	$1.0B+67.6%	$610.6M+2.9%	$593.6M-1.1%	$600.3M-0.6%	$604.1M-5.3%	$637.8M-0.3%	$639.4M+109.4%	$305.3M-19.7%	$380.1M
Cash & Equivalents	$164.8M-17.3%	$199.3M-17.9%	$242.9M+4.6%	$232.2M-47.9%	$446.1M+47.6%	$302.2M-24.3%	$399.0M+612.5%	$56.0M-15.2%	$66.0M+26.9%	$52.0M+7.7%	$48.3M-16.7%	$58.0M+35.8%	$42.7M+111.4%	$20.2M-82.5%	$115.5M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$344.0M-34.5%	$525.2M-11.4%	$592.6M+22.0%	$485.6M+18.0%	$411.6M+6.8%	$385.4M+144.4%	$157.7M-8.6%	$172.5M+13.8%	$151.6M-1.0%	$153.1M-0.3%	$153.6M-8.8%	$168.5M-5.1%	$177.5M+97.2%	$90.0M+7.5%	$83.7M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.6B-12.8%	$1.8B-9.5%	$2.0B+76.2%	$1.2B-0.8%	$1.2B+2.0%	$1.1B+141.7%	$470.7M-0.4%	$472.5M-27.0%	$647.5M+2.1%	$634.3M+16.6%	$544.0M-4.7%	$570.7M-2.6%	$585.8M+92.9%	$303.7M+1.2%	$300.0M
Total Liabilities	$3.0B-19.5%	$3.8B-2.7%	$3.9B+40.8%	$2.8B-0.8%	$2.8B-4.3%	$2.9B+99.3%	$1.5B+30.2%	$1.1B-5.9%	$1.2B-9.4%	$1.3B+9.2%	$1.2B-9.2%	$1.3B-7.2%	$1.4B+145.5%	$581.2M-21.2%	$737.6M
Current Liabilities	$1.0B-14.2%	$1.2B-7.9%	$1.3B+19.8%	$1.1B+4.1%	$1.0B+21.5%	$852.1M+44.6%	$589.3M+10.8%	$531.7M+3.9%	$511.7M+18.0%	$433.7M+7.3%	$404.2M-17.7%	$491.1M+5.5%	$465.5M+206.7%	$151.8M+11.5%	$136.2M
Non-Current Liabilities	$2.0B-22.0%	$2.6B-0.1%	$2.6B+54.2%	$1.7B-3.8%	$1.7B-15.0%	$2.1B+136.4%	$869.5M+47.7%	$588.8M-13.3%	$678.9M-22.8%	$879.8M+10.2%	$798.1M-4.3%	$833.6M-13.3%	$961.4M+123.9%	$429.4M-28.6%	$601.4M
Long-Term Debt	$1.5B-19.8%	$1.9B-5.9%	$2.0B+62.9%	$1.2B+0.8%	$1.2B-20.0%	$1.5B+144.8%	$619.5M+79.8%	$344.6M-22.9%	$446.9M-24.9%	$595.1M+14.7%	$518.7M-4.6%	$543.5M-16.9%	$654.3M+140.9%	$271.6M-37.1%	$431.5M
Total Equity	$1.4B-2.6%	$1.4B-12.7%	$1.6B+50.5%	$1.1B-10.5%	$1.2B+14.2%	$1.1B+40.4%	$754.1M+3.1%	$731.1M-2.7%	$751.4M+18.8%	$632.3M+6.4%	$594.1M+1.9%	$583.3M+2.6%	$568.3M+12.2%	$506.3M+14.3%	$443.1M
Retained Earnings	$1.0B-2.0%	$1.0B-20.8%	$1.3B+62.5%	$812.0M+21.9%	$666.2M+38.4%	$481.4M-19.7%	$599.5M+12.9%	$531.0M+4.7%	$507.1M+17.0%	$433.3M+16.4%	$372.1M+19.4%	$311.7M+23.6%	$252.2M+5.8%	$238.3M+30.4%	$182.7M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$4.5B-11.7%	$4.5B-14.7%	$4.7B-11.3%	$4.8B-13.7%	$5.1B-9.4%	$5.2B-5.6%	$5.3B+11.4%	$5.6B+15.3%
Current Assets	N/A	$1.2B-17.8%	$1.3B-21.4%	$1.5B-7.8%	$1.5B-7.3%	$1.5B-6.1%	$1.6B+3.4%	$1.6B-1.7%
Cash & Equivalents	$173.1M-16.8%	$164.8M-17.3%	$162.8M-27.3%	$458.4M+104.3%	$208.0M+4.8%	$199.3M-17.9%	$223.8M-23.0%	$224.4M-28.8%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$349.4M-33.0%	$344.0M-34.5%	$386.2M-32.7%	$370.6M-37.1%	$521.7M-14.1%	$525.2M-11.4%	$573.5M+0.9%	$588.9M+0.1%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.6B-9.6%	$1.6B-12.8%	$1.7B-5.8%	$1.6B-20.8%	$1.8B-13.7%	$1.8B-9.5%	$1.8B+14.5%	$2.0B+31.0%
Total Liabilities	$3.0B-16.3%	$3.0B-19.5%	$3.3B-13.2%	$3.4B-11.4%	$3.6B-5.8%	$3.8B-2.7%	$3.8B+25.6%	$3.9B+22.9%
Current Liabilities	N/A	$1.0B-14.2%	$1.0B-15.1%	$994.2M-18.0%	$1.1B-11.5%	$1.2B-7.9%	$1.2B+2.9%	$1.2B-7.7%
Non-Current Liabilities	N/A	$2.0B-22.0%	$2.3B-12.3%	$2.5B-8.4%	$2.6B-3.1%	$2.6B-0.1%	$2.6B+40.0%	$2.7B+44.7%
Long-Term Debt	$1.6B-17.4%	$1.5B-19.8%	$1.7B-19.6%	$1.9B-9.3%	$1.9B-6.8%	$1.9B-5.9%	$2.1B+55.6%	$2.1B+60.1%
Total Equity	$1.4B+2.8%	$1.4B-2.6%	$1.3B-6.6%	$1.3B-19.6%	$1.4B-18.2%	$1.4B-12.7%	$1.4B-14.8%	$1.7B+0.9%
Retained Earnings	$1.0B-2.9%	$1.0B-2.0%	$964.2M-7.9%	$978.4M-25.4%	$1.0B-21.6%	$1.0B-20.8%	$1.0B-20.5%	$1.3B+1.7%

Not reported in any period shown, so not listed: Accounts Receivable.

HI Cash Flow Statement

HI quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$40.1M	$56.2M-70.6%	$191.3M-7.6%	$207.0M+8.3%	$191.1M-63.8%	$528.4M+48.9%	$354.8M+98.3%	$178.9M-28.0%	$248.3M+0.9%	$246.2M+3.4%	$238.2M+126.9%	$105.0M-41.5%	$179.6M+41.2%	$127.2M-8.0%	$138.2M-27.1%	$189.5M
Depreciation & Amortization	N/A	$138.5M-12.3%	$158.0M+25.8%	$125.6M+27.4%	$98.6M-5.7%	$104.6M-19.9%	$130.6M+123.2%	$58.5M+3.5%	$56.5M-0.2%	$56.6M-6.3%	$60.4M+11.2%	$54.3M-7.0%	$58.4M-34.7%	$89.4M+121.3%	$40.4M+11.9%	$36.1M
Stock-Based Compensation	N/A	$17.9M-11.8%	$20.3M+8.0%	$18.8M-1.1%	$19.0M+9.2%	$17.4M+24.3%	$14.0M+16.7%	$12.0M-0.8%	$12.1M+15.2%	$10.5M+23.5%	$8.5M-29.2%	$12.0M+60.0%	$7.5M+17.2%	$6.4M-26.4%	$8.7M-25.6%	$11.7M
Capital Expenditures	$32.3M	$38.3M-29.3%	$54.2M-21.8%	$69.3M+80.9%	$38.3M+35.8%	$28.2M-21.4%	$35.9M+40.8%	$25.5M-5.6%	$27.0M+22.7%	$22.0M+3.8%	$21.2M-31.6%	$31.0M+31.4%	$23.6M-21.1%	$29.9M+43.1%	$20.9M-4.6%	$21.9M
Free Cash Flow	$7.8M	$17.9M-86.9%	$137.1M-0.4%	$137.7M-9.9%	$152.8M-69.5%	$500.2M+56.9%	$318.9M+107.9%	$153.4M-30.7%	$221.3M-1.3%	$224.2M+3.3%	$217.0M+193.2%	$74.0M-52.6%	$156.0M+60.3%	$97.3M-17.1%	$117.3M-30.0%	$167.6M
Investing Cash Flow	N/A	N/A	N/A	N/A	-$143.4M-213.8%	$126.0M+109.7%	-$1.3B-2431.1%	-$51.2M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	-$275.0M	-$279.4M-23.0%	-$227.1M-132.8%	$693.4M+383.9%	-$244.2M+53.3%	-$523.3M-161.2%	$854.9M+293.1%	$217.5M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	$63.7M	$63.4M+1.4%	$62.5M+2.0%	$61.3M-1.1%	$62.0M-3.1%	$64.0M+0.9%	$63.4M+20.5%	$52.6M+1.0%	$52.1M+0.4%	$51.9M+1.6%	$51.1M+1.4%	$50.4M+1.4%	$49.7M+2.1%	$48.7M+2.3%	$47.6M+1.5%	$46.9M
Share Buybacks	N/A	N/A	$0	$0-100.0%	$203.9M+68.4%	$121.1M	$0	$0-100.0%	$61.0M+117.9%	$28.0M+32.1%	$21.2M+89.3%	$11.2M-32.1%	$16.5M	$0-100.0%	$22.5M+492.1%	$3.8M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	-$27.4M-142.5%	$67.7M-59.3%	-$1.5M-103.3%	$1.3M-59.4%	-$11.3M+52.9%	$166.5M+126.8%	$45.6M-48.7%	$3.2M-93.6%
Depreciation & Amortization	$33.0M-12.9%	$33.8M-13.8%	$32.7M-15.7%	$34.1M-17.2%	$37.9M-2.3%	$39.2M+20.6%	$38.8M+24.8%	$41.2M+32.9%
Stock-Based Compensation	$4.7M0.0%	N/A	$4.0M-20.0%	$5.8M+23.4%	$4.7M-9.6%	N/A	$5.0M+2.0%	$4.7M+4.4%
Capital Expenditures	$4.2M-58.8%	$9.1M-30.5%	$9.7M-39.0%	$9.3M-27.3%	$10.2M-17.7%	$13.1M-43.5%	$15.9M+14.4%	$12.8M-24.3%
Free Cash Flow	-$31.6M-47.0%	$58.6M-61.8%	-$11.2M-137.7%	-$8.0M+16.7%	-$21.5M+40.9%	$153.4M+205.6%	$29.7M-60.4%	-$9.6M-128.7%
Financing Cash Flow	$31.2M+16.4%	-$172.4M+28.3%	-$295.4M-800.6%	$161.6M+155.3%	$26.8M+256.7%	-$240.5M-135.8%	-$32.8M-305.0%	$63.3M+110.5%
Dividends Paid	$16.1M+1.9%	$15.9M+1.3%	$15.8M+1.3%	$15.9M+1.9%	$15.8M+1.3%	$15.7M+1.9%	$15.6M+2.0%	$15.6M+2.0%

Not reported in any period shown, so not listed: Investing Cash Flow, Share Buybacks.

HI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HI quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	33.7%+0.5pp	33.2%-0.4pp	33.6%+0.6pp	33.0%+0.3pp	32.7%+0.4pp	32.3%-2.2pp	34.5%-1.8pp	36.3%-0.9pp	37.1%+0.1pp	37.1%+1.4pp	35.7%+0.4pp	35.3%+2.0pp	33.4%-6.2pp	39.6%-2.3pp	41.9%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	10.5%+2.9pp	7.6%-7.5pp	15.1%-2.8pp	17.9%
Net Margin	1.6%+8.2pp	-6.6%-26.8pp	20.2%+11.1pp	9.0%-2.1pp	11.2%+13.3pp	-2.1%-9.1pp	7.0%+2.4pp	4.6%-3.5pp	8.1%+0.5pp	7.6%+0.5pp	7.1%+0.4pp	6.7%+2.5pp	4.2%-6.5pp	10.7%-1.3pp	12.0%
Return on Equity	3.1%+17.9pp	-14.8%-49.8pp	34.9%+15.7pp	19.3%-1.4pp	20.7%+25.7pp	-5.0%-21.8pp	16.7%+5.6pp	11.1%-6.0pp	17.1%-1.4pp	18.5%-0.6pp	19.1%0.0pp	19.1%+7.5pp	11.5%-9.2pp	20.7%-3.2pp	23.9%
Return on Assets	1.0%+5.0pp	-4.0%-14.3pp	10.3%+4.9pp	5.4%-0.8pp	6.2%+7.6pp	-1.3%-7.0pp	5.7%+1.3pp	4.3%-2.2pp	6.6%+0.6pp	6.0%-0.3pp	6.3%+0.5pp	5.8%+2.5pp	3.3%-6.4pp	9.6%+0.7pp	9.0%
Current Ratio	1.22-0.1x	1.270.0x	1.25-0.1x	1.30-0.1x	1.39-0.2x	1.61-0.1x	1.74+0.6x	1.150.0x	1.16-0.2x	1.38-0.1x	1.49+0.2x	1.30-0.1x	1.37-0.6x	2.01-0.8x	2.79
Debt-to-Equity	1.08-0.2x	1.32+0.1x	1.22+0.1x	1.13+0.1x	1.00-0.4x	1.43+0.6x	0.82+0.4x	0.47-0.1x	0.59-0.3x	0.94+0.1x	0.87-0.1x	0.93-0.2x	1.15+0.6x	0.54-0.4x	0.97
Asset Turnover	0.600.0x	0.61+0.1x	0.51-0.1x	0.600.0x	0.56-0.1x	0.63-0.2x	0.81-0.1x	0.95+0.1x	0.810.0x	0.79-0.1x	0.880.0x	0.87+0.1x	0.78-0.1x	0.90+0.2x	0.75
FCF Margin	0.7%-3.6pp	4.3%-0.6pp	4.9%-1.7pp	6.6%-15.7pp	22.3%+9.7pp	12.7%+4.2pp	8.5%-4.0pp	12.5%-1.6pp	14.1%0.0pp	14.1%+9.5pp	4.6%-4.7pp	9.4%+3.1pp	6.3%-5.7pp	11.9%-7.0pp	19.0%

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Gross Margin	33.4%+0.2pp	34.8%+0.4pp	33.8%0.0pp	33.0%+1.1pp	33.2%+0.8pp	34.4%-0.7pp	33.9%-0.6pp	31.9%-0.8pp
Net Margin	-0.4%-1.3pp	11.6%+9.9pp	0.3%+32.0pp	-5.7%-6.5pp	0.9%-1.3pp	1.7%-0.7pp	-31.6%-37.7pp	0.8%-66.2pp
Return on Equity	-0.1%-0.6pp	5.5%+4.4pp	0.1%+17.8pp	-3.1%-3.5pp	0.5%-0.6pp	1.0%-0.1pp	-17.7%-20.3pp	0.4%-27.9pp
Return on Assets	-0.1%-0.2pp	1.7%+1.4pp	0.0%+4.8pp	-0.9%-1.0pp	0.1%-0.2pp	0.3%-0.1pp	-4.7%-5.6pp	0.1%-9.5pp
Current Ratio	N/A	1.22-0.1x	1.25-0.1x	1.51+0.2x	1.34+0.1x	1.270.0x	1.350.0x	1.34+0.1x
Debt-to-Equity	1.10-0.3x	1.08-0.2x	1.26-0.2x	1.43+0.2x	1.36+0.2x	1.32+0.1x	1.47+0.7x	1.26+0.5x
Asset Turnover	0.120.0x	0.150.0x	0.130.0x	0.150.0x	0.140.0x	0.160.0x	0.150.0x	0.140.0x
FCF Margin	-5.7%-2.7pp	9.0%-9.3pp	-1.9%-5.7pp	-1.1%+0.1pp	-3.0%+1.7pp	18.3%+11.7pp	3.8%-6.7pp	-1.2%-6.1pp

Not reported in any period shown, so not listed: Operating Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Hillenbrand, Inc. HI	FY2025	$2.7B	$43.1M	1.6%	$2.3B	22/100
Helios Technologies, Inc. HLIO	FY2025	$839.0M	$48.4M	5.8%	$2.4B	55/100
TENNANT COMPANY TNC	FY2025	$1.2B	$43.8M	3.6%	$1.2B	52/100
Nano Nuclear Energy Inc. NNE	FY2025	N/A	-$40.1M	N/A	$885.5M	—
The Gorman-Rupp Company GRC	FY2025	$682.4M	$53.0M	7.8%	$2.0B	59/100
THERMON GROUP HOLDINGS, INC. THR	FY2026	$536.3M	$44.6M	8.3%	$2.0B	65/100

Where Hillenbrand, Inc. Ranks

Frequently Asked Questions

What is Hillenbrand, Inc.'s annual revenue?

Hillenbrand, Inc. (HI) reported $2.7B in total revenue for fiscal year 2025. This represents a -16.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Hillenbrand, Inc.'s revenue growing?

Hillenbrand, Inc. (HI) revenue declined by 16.0% year-over-year, from $3.2B to $2.7B in fiscal year 2025.

Is Hillenbrand, Inc. profitable?

Yes, Hillenbrand, Inc. (HI) reported a net income of $43.1M in fiscal year 2025, with a net profit margin of 1.6%.

How much debt does Hillenbrand, Inc. have?

As of fiscal year 2025, Hillenbrand, Inc. (HI) had $164.8M in cash and equivalents against $1.5B in long-term debt.

What is Hillenbrand, Inc.'s gross margin?

Hillenbrand, Inc. (HI) had a gross margin of 33.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Hillenbrand, Inc.'s net profit margin?

Hillenbrand, Inc. (HI) had a net profit margin of 1.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Hillenbrand, Inc. pay dividends?

Yes, Hillenbrand, Inc. (HI) paid $0.90 per share in dividends during fiscal year 2025.

What is Hillenbrand, Inc.'s return on equity (ROE)?

Hillenbrand, Inc. (HI) has a return on equity of 3.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Hillenbrand, Inc.'s free cash flow?

Hillenbrand, Inc. (HI) generated $17.9M in free cash flow during fiscal year 2025. This represents a -86.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Hillenbrand, Inc.'s operating cash flow?

Hillenbrand, Inc. (HI) generated $56.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Hillenbrand, Inc.'s total assets?

Hillenbrand, Inc. (HI) had $4.5B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Hillenbrand, Inc.'s capital expenditures?

Hillenbrand, Inc. (HI) invested $38.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Hillenbrand, Inc. spend on research and development?

Hillenbrand, Inc. (HI) invested $34.1M in research and development during fiscal year 2025.

How many shares does Hillenbrand, Inc. have outstanding?

Hillenbrand, Inc. (HI) had 71M shares outstanding as of fiscal year 2025.

What is Hillenbrand, Inc.'s current ratio?

Hillenbrand, Inc. (HI) had a current ratio of 1.22 as of fiscal year 2025, which is considered adequate.

What is Hillenbrand, Inc.'s debt-to-equity ratio?

Hillenbrand, Inc. (HI) had a debt-to-equity ratio of 1.08 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Hillenbrand, Inc.'s return on assets (ROA)?

Hillenbrand, Inc. (HI) had a return on assets of 1.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Hillenbrand, Inc.'s Piotroski F-Score?

Hillenbrand, Inc. (HI) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Hillenbrand, Inc.'s earnings high quality?

Hillenbrand, Inc. (HI) has an earnings quality ratio of 1.30x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Hillenbrand, Inc.?

Hillenbrand, Inc. (HI) scores 22 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.